Hypertriglyceridemia-induced pancreatitis and risk of persistent systemic inflammatory response syndrome

Am J Med Sci. 2015 Mar;349(3):206-11. doi: 10.1097/MAJ.0000000000000392.

Abstract

Background: The mechanisms responsible for the development of acute pancreatitis (AP) and its complications are not fully understood.

Aim: To assess the role of clinical and host molecular factors for the development and outcome of persistent systemic inflammatory response syndrome (SIRS) in patients with AP.

Methods: We included 191 patients with AP in the study. The considered variables were demographic characteristics, prognosis and outcome, etiology, laboratory findings and complications. Interleukin (IL) 10 (-1082 G/A, -592 C/A), TNFA-308 (G/A) and ILB-31 (C/T) polymorphisms were determined by pyrosequencing. An amplification refractory mutation system-polymerase chain reaction method was used to genotype the IL8-251 (A/T) polymorphism.

Results: Demographic characteristics were not statistically significant risk factors for the acquisition of persistent SIRS in patients with AP. Patients with hypertriglyceridemia were more likely to develop persistent SIRS (P < 0.05). No association with the TNFA, ILB, IL8-251 (A/T) and IL10 single-nucleotide polymorphisms was detected from the allele, genotype or haplotype frequencies.

Conclusions: Patients with hypertriglyceridemia-induced AP were more likely to develop persistent SIRS.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Cytokines / genetics
  • Female
  • Humans
  • Hypertriglyceridemia / complications*
  • Male
  • Middle Aged
  • Pancreatitis / complications*
  • Polymorphism, Single Nucleotide
  • Prospective Studies
  • Systemic Inflammatory Response Syndrome / etiology*
  • Young Adult

Substances

  • Cytokines